Professional Mammary Gland Therapeutic Apparatus PKR-1

MAMMARY  GLAND  THERAPEUTIC  APPARATUS  PKR-1 Model

Expert panel’s evaluation comments and conclusions regarding this product:”this product mainly applies photochemical effect. Light could have act to the depth of submucous layer, with an effective penetration depth up to 1-4cm, which could improve local blood circulation, enhance metabolism, having an obvious effect of anti-inflammation, detumescence as well as easing spasmolysis and adjusting human immunity and neural function.”

Results of clinical verification:

Method: Apply the Mammary Gland Therapeutic Apparatus developed by Hebei Pukang Medical Instruments Co., Ltd. According to one or both breasts as well as single or multiple lesion, place the light source to hyperplasia lesion for direct radiation therapy. Each therapy lasts for 20 minutes, and one time per day. One course means 15 times, could perform two coursed in succession, with a interval of 5-7 days. Long term use is acceptable.

Curative effect assessment criteria:

Clinical cured: Phyma and breast pain disappear.

Significant effective: Phyma maximum diameter shrinks by half, and breast pain disappear.

Effective: Phyma maximum diameter shrinks less than half, breast pain eased; Or phyma maximum diameter shrinks more than half, while breast pain remain the same.

Ineffective: Phyma does not shrink or even grow up, or only breast pain eased, but phyma remain the same.

Result: Treat 30 patients with an average of 24.67±7.4 radiation therapys, 5 patients are clinically cured, which accounts for 9% of the total; 28 patients are significantly effective, which accounts for 47% of the total; 3 patients are ineffective, which accounts for 5%of the total; Significantly effective rate amounts to 55%; The total effectiveness rate of treatment is 95%.